Fitzgerald Meghan
SEC Form 4 insider trading activity
Fitzgerald Meghan has filed 8 SEC Form 4 filings (14 transaction rows) across 2 companies, including ROIV, THC, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Sep 18, 2026.
On the most recent filing, Fitzgerald Meghan is listed as Director at Roivant Sciences Ltd. Inside the rolling window, Fitzgerald Meghan reported no open-market purchases and 4 open-market sales totaling $3.3M in ROIV. The largest disclosed transaction in the window is a sale of 70,000 ROIV shares on Mar 26, 2026, worth $1.9M.
Companies traded
Other insiders at ROIV
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.3M
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Fitzgerald Meghan made?
Fitzgerald Meghan has filed 8 SEC Form 4 filings (14 transaction rows) across 2 companies, including ROIV, THC since 2025.
Which companies does Fitzgerald Meghan trade?
Fitzgerald Meghan has filed SEC Form 4 disclosures for 2 companies, including ROIV, THC.
When was Fitzgerald Meghan's most recent SEC Form 4 filing?
Fitzgerald Meghan's most recent SEC Form 4 filing on Tracefour is dated Sep 18, 2026.
What is Fitzgerald Meghan's total buy and sell value in the current window?
Inside the rolling retention window, Fitzgerald Meghan bought $0 and sold $3.3M based on SEC Form 4 filings.
What was Fitzgerald Meghan's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 70,000 ROIV shares on 2026-03-26, worth $1.9M, per SEC Form 4 filings.